Volver

Becton Dickinson and Company

Ticker: BDX ISIN: US0758871091
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap Dividend payer
Capitalización
58,89 MM $
P/E
34,47
Forward P/E
14,62
Profit margin
8,37%
Revenue growth QoQ
9,80%
Div. yield
1,95%
Beta
0,38
189,78 $ -0,50%
Precio a fecha de 2026-08-25 · NYSE

Rendimiento por período

Rendimientos acumulados
1 Month +19,42%
6 Months +6,29%
1 Year +27,44%
5 Years +1,67% p.a.+8,63%
10 Years +5,02% p.a.+63,09%
Since inception +9,73% p.a.+916,71%
Rendimientos por año
YTD +26,07%
2025 -12,61%
2024 -5,38%
2023 -2,67%
2022 +5,08%
2021 +1,88%

Key stats

Market cap
58,89 MM
P/E
34,47
Dividend yield
1,95%
Beta
0,38
52-week range
193.03 - 250.85
50-day MA
219,79
200-day MA
230,24
Section 1

Business overview

Company profile data from fundamentals.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Sector Healthcare
Industry Medical Instruments & Supplies
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 6,84%
ROA 3,70%
Profit margin 8,37%
Operating margin 15,27%
PEG ratio 0,94
Revenue/share TTM 71,27
Revenue TTM 20,64 MM
EBITDA 5,50 MM
Gross profit TTM 9,55 MM
Beta 0,38

Valuation

Trailing P/E 34,47
Forward P/E 14,62
P/B 2,34
P/S 2,85
EV/EBITDA 15,84
EV/Revenue 3,73

ESG Scores

Total ESG 33,8
Environment 4,9
Social 20,1
Governance 13,8
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 14,37
Quarterly earnings growth 8,30%
Revenue TTM 20,64 MM
Reported quarters 123
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 1,95%
Forward annual div. yield 1,95%
Dividend per share 3,8900
Payout ratio 28,61%
Ex-dividend date 2025-03-10
Split factor 1025:1000
Last split date 2022-04-01
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 275,03 $
Analyst rating 4.2353

Ownership & short interest

Shares outstanding 287,14 M
Shares float 286,45 M
Institutional ownership 93,86%
Insider ownership 55,90%
Short ratio 1,88
Short % of float 1,32%

Details

Instrument metadata and source update timestamps.

Symbol BDX
Name Becton Dickinson and Company
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US0758871091
Country USA
Code + exchange BDX.NYSE
Last price date 2025-04-25
Fundamentals updated 2025-04-26

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.